ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

OMGA Omega Therapeutics Inc

2.1601
-0.1199 (-5.26%)
08 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Omega Therapeutics Inc OMGA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.1199 -5.26% 2.1601 09:00:00
개장가 저가 고가 종가 전일 종가
2.35 2.15 2.37 2.155 2.28
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/05/202420:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/05/202420:04EDGAR2Form 8-K - Current report
06/05/202420:00GLOBEOmega Therapeutics Reports First Quarter 2024 Financial..
23/04/202420:00GLOBEOmega Therapeutics to Present New Preclinical Data on..
09/04/202420:00GLOBEOmega Therapeutics Presents New Preclinical Data at AACR..
28/03/202422:15GLOBEOmega Therapeutics Reports Fourth Quarter and Full Year 2023..
06/03/202421:00GLOBEOmega Therapeutics Announces Two Poster Presentations at the..
10/02/202407:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:00EDGAR2Form 8-K - Current report
03/01/202406:05GLOBEOmega Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/12/202306:00EDGAR2Form 8-K - Current report
05/12/202306:00GLOBEOmega Therapeutics to Participate in the H.C. Wainwright 4th..
28/11/202309:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202320:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
21/11/202306:00GLOBEOmega Therapeutics to Participate in the Piper Sandler 35th..
13/11/202321:00GLOBEOmega Therapeutics Showcases Bidirectional and Multiplexed..
09/11/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:03EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEOmega Therapeutics Reports Third Quarter 2023 Financial..
08/11/202306:00GLOBEOmega Therapeutics to Participate in The Jefferies London..
31/10/202320:00GLOBEOmega Therapeutics Presents New Preclinical Data..
16/10/202320:00GLOBEOmega Therapeutics Presents New Preclinical Data Supporting..
12/10/202305:00GLOBEOmega Therapeutics Announces Two Poster Presentations on..
05/10/202305:00GLOBEOmega Therapeutics to Present New Preclinical Data on..
27/09/202306:29EDGAR2Form 8-K - Current report
26/09/202320:00GLOBEOmega Therapeutics Announces Promising Preliminary Clinical..
26/09/202305:00GLOBEOmega Therapeutics to Host Conference Call to Discuss..
23/09/202306:10EDGAR2Form 8-K - Current report
22/09/202305:00GLOBEOmega Therapeutics to Participate in Two Upcoming Investor..
11/09/202319:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/08/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/08/202320:03EDGAR2Form 8-K - Current report
29/08/202320:00GLOBEOmega Therapeutics Announces Updates to its Board of..
04/08/202306:13EDGAR2Form 8-K - Current report
04/08/202306:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/08/202305:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:00GLOBEOmega Therapeutics Reports Second Quarter 2023 Financial..
14/07/202305:00EDGAR2Form 8-K - Current report
13/07/202305:01EDGAR2Form 8-K - Current report
12/07/202320:00GLOBEOmega Therapeutics Appoints Chris Schade to its Board of..
01/06/202320:00GLOBEOmega Therapeutics to Participate in Two Upcoming Investor..
31/05/202321:30GLOBEAshvattha Therapeutics Expands Leadership Team with..
31/05/202320:00GLOBEOmega Therapeutics Presents New Preclinical Data..
16/05/202319:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

최근 히스토리

Delayed Upgrade Clock